Eicosapentaenoic acid and docosahexaenoic acid reduce interleukin-1β-mediated cartilage degradation
2010

Eicosapentaenoic acid and docosahexaenoic acid reduce cartilage degradation

Sample size: 10 publication Evidence: moderate

Author Information

Author(s): Wann Angus KT, Mistry Jiten, Blain Emma J, Michael-Titus Adina T, Knight Martin M

Primary Institution: Queen Mary University of London

Hypothesis

The long-chain n-3 fatty acids, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), reduce cytokine-induced articular cartilage degradation.

Conclusion

n-3 PUFAs, particularly EPA, have therapeutic potential for preventing cartilage degradation associated with chronic inflammatory joint disease.

Supporting Evidence

  • IL-1β treatment significantly increased sGAG release compared to controls.
  • EPA and DHA at low concentrations reduced IL-1β-mediated sGAG loss.
  • EPA maintained its efficacy over the treatment period, while DHA's efficacy decreased.

Takeaway

This study found that certain fish oils can help protect cartilage from damage caused by inflammation.

Methodology

Bovine cartilage explants were cultured with or without IL-1β and treated with EPA and DHA at varying concentrations, measuring sGAG release.

Limitations

The study used an in vitro model, which may not fully replicate in vivo conditions.

Participant Demographics

Bovine cartilage explants from 18-month-old steers.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1186/ar3183

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication